Published online before print February 10, 2005, doi: 10.1161/01.ATV.0000158497.09626.3b
© 2005 American Heart Association, Inc.
Brief Reviews |
Redox Modulation of Vascular Tone
Focus of Potassium Channel Mechanisms of Dilation
From the Cardiovascular Center, Department of Medicine, General Clinical Research Center, VA Medical Center, Medical College of Wisconsin, Milwaukee.
Correspondence to David Gutterman, Medical College of Wisconsin, Cardiovascular Research Center, Milwaukee WI 53226. E-mail dgutt{at}mcw.edu
Series Editor: Kathy K. Griendling
Redox Mechanisms in Blood Vessels
ATVB In Focus
Previous Brief Review in this Series:
•Mueller CFH, Laude K, McNally JS, Harrison DG. Redox mechanisms in blood vessels. 2005;25:274–278.
 |
Abstract |
|---|
 Top Abstract IntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
Opening of potassium channels on vascular smooth muscle cells with resultant hyperpolarization plays a central role in several mechanisms of vasodilation. For example, in the arteriolar circulation where tissue perfusion is regulated, there is an endothelial derived hyperpolarizing factor that opens vascular smooth muscle calcium-activated potassium channels, eliciting dilation. Metabolic vasodilation involves the opening of sarcolemmal ATP-sensitive potassium channels. Adrenergic dilation as well as basal vasomotor tone in several vascular beds depend upon voltage-dependent potassium channels in smooth muscle. Thus hyperpolarization through potassium channel opening is a fundamental mechanism for vasodilation. Disease states such as coronary atherosclerosis and its risk factors are associated with elevated levels of reactive oxygen (ROS) and nitrogen species that have well-defined inhibitory effects on nitric oxide–mediated vasodilation. Effects of ROS on hyperpolarization mechanisms of dilation involving opening of potassium channels are less well understood but are very important because hyperpolarization-mediated dilation often compensates for loss of other dilator mechanisms. We review the effect of ROS on potassium channel function in the vasculature. Depending on the oxidative species, ROS can activate, inhibit, or leave unaltered potassium channel function in blood vessels. Therefore, discerning the activity of enzymes regulating production or degradation of ROS is important when assessing tissue perfusion in health and disease.
Opening of potassium channels on vascular smooth muscle cells with resultant hyperpolarization plays a central role in several mechanisms of vasodilation. Disease states such as coronary atherosclerosis and its risk factors are associated with elevated levels of reactive oxygen (ROS) and nitrogen species that have well-defined inhibitory effects on nitric oxide–mediated vasodilation. Depending on the oxidative species, ROS can activate, inhibit, or leave unaltered potassium channel function in blood vessels. Therefore, discerning the activity of enzymes regulating production or degradation of ROS is important when assessing tissue perfusion in health and disease.
Key Words: hyperpolarization factor • reactive oxygen species • antioxidant • vasodilation
|
Introduction |
|---|
|
TopAbstractIntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
The vascular oxidative state is modulated by physiological stimuli such as endothelial shear1–4 and myogenic stretch,5,6 as well as pathophysiological stress including hyperglycemia,7,8 hypertension,9,10 hyperlipidemia,11,12 tobacco use,13,14 and even immunization.15 Reactive oxygen species (ROS) are generated either from the underlying tissues or from within any layer of the vascular wall itself.16–18 The ubiquitous nature of ROS in and around the vasculature is consistent with an important modulatory effect on vascular function. One manifestation of this influence is the reduced nitric oxide (NO)-mediated dilation that is typically observed in vessels from animals or patients with atherosclerosis or its risk factors. In these conditions excess ROS production and/or impaired quenching of radical species leads to a redox imbalance that reduces NO bioavailability, abrogating an important endothelium-dependent mechanism of dilation. Shear stress or locally released chemical substances such as adenosine diphosphate (ADP), bradykinin, or serotonin, which dilate normal conduit vessels, produce no dilation or even paradoxical constriction in the presence of excess ROS.19,20 This may have profound effects on tissue perfusion, especially later in the course of disease when physiological stimuli, such as sympathetic activation,21–23 which normally elicits dilation, instead produce frank constriction at the site of a flow-limiting stenosis where endothelial function is reduced.21
ROS-mediated loss of NO, through either direct quenching24,25 or impaired synthesis,26,27 affects humoral28 and metabolic dilator mechanisms.29.
Although the detrimental effects of ROS on NO-mediated dilation have been extensively studied, the effects of ROS on other dilator mechanisms are largely unknown. This review discusses the effect of ROS on an important NO-independent mechanism of dilation, namely, opening of potassium channels in vascular smooth muscle. The concepts outlined in the current review are depicted in a diagram outlining the influence of ROS on hyperpolarization-mediated dilation (Figure). We highlight recent findings that suggest dilator mechanisms operating through the opening of potassium channels have a different sensitivity to oxidative stress than NO-mediated dilator pathways. This may have significant functional consequences because in the absence of NO, hyperpolarization-induced mechanisms of dilation often assume greater importance.30,31 Emphasis is placed on the coronary circulation, including data from experiments using human tissue when possible. Certain aspects of this topic have been recently reviewed by Ellis and Triggle.32
|
Major potassium channels in the vasculature include calcium-activated potassium channels (KCa), which can mediate responses to endothelium-derived hyperpolarization factor (EDHF)30,33–35 and which serve to buffer the magnitude of vasoconstriction to increases in vascular myocyte calcium, sarcolemmal ATP-sensitive potassium channels (KATP), which are important in metabolic dilation,36,37 and members of the voltage-dependent potassium channel family (Kv), which contribute to resting vasomotor tone and cAMP-mediated vasodilation.8 It is important to consider the integrity of each of these dilator mechanisms that may be affected by disease states in which ROS levels are elevated.
|
Redox Modulation of KCa Activity |
|---|
|
TopAbstractIntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
When considering oxidative modulation of KCa activity, it is important to note that the KCa channel family consists of small conductance, (SKCa), intermediate conductance (IKCa,) and large conductance Ca2+-activated K+ channel (BKCa) subtypes, each with different gating properties, redox sensitivities, and structural components (BKCa have
-subunit and ß-subunit proteins). BKCa and IKCa exist on endothelium38,39 and vascular smooth muscle cells (VSMCs),40,41 whereas SKCa are primarily located on the endothelium,42 although species variability exists.43 The effects of ROS on vascular KCa channel responses depend on the specific KCa channel and the ROS species studied. Because BKCa are most prominent in the vasculature and are involved in hyperpolarization-mediated dilation, they are discussed in this review.
The BKCa channel contains 6 transmembrane segments (S1 to S6) and a highly conserved pore region between S5 and S6.44 The voltage sensor is located at S4. Ca2+ sensitivity of the KCa channel is conferred by an extra 4 transmembrane segments (S7 to S10) at the C-terminal region of the -subunit, and by close association with a single regulatory ß-subunit.45 Interaction between the -subunit and ß-subunit greatly enhances Ca2+ sensitivity of BKCa channels.
Although superoxide generally exerts its vasomotor effects through dismutation to H2O2,46 superoxide itself elicits dilation of feline cerebral arteries in a KCa-dependent fashion.47 It is interesting that superoxide, which potently inhibits endothelial NO-mediated dilation, can stimulate dilation itself or can be spontaneously converted to the dilator H2O2. Dilations to both ROS appear KCa-sensitive. The situation is complicated by the fact that NO, a free-radical species itself, has direct activity on KCa in some vascular beds.39,48 Nevertheless hyperpolarization mechanisms of dilation produced by opening KCa and mediated by ROS such as H2O2 may compensate for loss of NO dilation in states of excess oxidative stress.
Cell-attached patch clamp measurements of isolated coronary arteriolar VSMCs show prominent activity of BKCa that is not altered by exposure to superoxide.49 Dilation to bradykinin was also studied. Bradykinin is an endothelium-dependent dilator of human coronary arterioles that operates through an EDHF mechanism, most likely by activating intermediate conductance KCa (IKCa) and small conductance KCa (SKCa) in the underlying smooth muscle.50 Bradykinin-induced dilation of isolated arterioles was unaffected by treatment with xanthine plus xanthine oxidase, a system for generating superoxide that impairs dilation to NO-mediated stimuli.49 This is consistent with observations by Zhang et al,51 who saw no effect of superoxide generated by ceramide on the EDHF-mediated component of dilation to bradykinin. However, these data contrast with observations by Armstead, who showed that vasopressin reduced KCa channel activity in an SOD-dependent fashion.52 Armstead’s study examined functional responses to an opener of BKCa channels, NS1619.53 In his preparation, this compound is a selective opener of BKCa channels,54 but in other studies it has been observed to inhibit calcium channels55 and Kv55 as well. The findings were not extended to identify the role of specific KCa channel affected (BKCa, IKCa, SKCa) or the role of other ROS including hydrogen peroxide (H2O2), hydroxyl radical, or peroxynitrite. A separate study by the same group in which piglet cerebral arterioles were exposed to hypoxanthine and xanthine oxidase to generate superoxide also observed reduced dilation to NS1619.56 However, a recent study has shown no inhibitory effect of superoxide on VSMC-type BKCa channels.57 These studies provide conflicting evidence of the effect of superoxide on BKCa channel activity.
Hydrogen peroxide, formed by the spontaneous or catalyzed dismutation of superoxide, can be a strong vasodilator,4,17,46 and either directly or indirectly through arachidonate metabolism opens KCa in several vascular beds58,59 including the coronary circulation,60 although other mechanisms also exist for H2O2-induced dilation.61,62 Oxidizing agents such as H2O2 can directly open KCa in isolated inside-out patches63 and specifically hyperpolarize VSMCs4 and open iberiotoxin-sensitive BKCa in endothelial cell membranes.64
However, dilation is not uniformly seen in response to H2O2, as some investigators observe constriction.39,65–67 Tang et al57 recently showed that H2O2 effectively eliminates physiological activation of vascular smooth muscle type BKCa reconstituted in HEK cells. Thus, the effect of H2O2 on vascular KCa is complex and may range from channel activation to inhibition depending on the subtype of channel present, whether the channel is on the endothelium or smooth muscle, dose, or on another incompletely defined conditions.
Additional radical species may also elicit dilation by activating BKCa. Nitrosative stress can modulate BKCa through an effect on sulfhydryl groups. For example, NO can enhance BKCa activity through S-nitrosylation of cysteine residues in the alpha subunit.68 However, some ROS potently inhibit BKCa channel activity. Brzezinska et al demonstrated in rat cerebral arterial smooth muscle cells that exposure to peroxynitrite produces a reversible inhibition of BKCa.69 In the human heart, peroxynitrite but not its decomposition products, markedly reduces opening probability of isolated inside-out patches of BKCa.49 This is associated with a reduction in iberiotoxin-sensitive whole cell currents.
These data show that peroxynitrite, in contrast to superoxide, inhibits BKCa activity in the human coronary circulation. This could influence prevailing vasomotor tone depending on the nature and amount of ROS present. Disease states such as diabetes or CAD are associated with excess superoxide formation that may quench NO, inhibiting this mechanism of dilation. Quenching of NO by superoxide is often compensated for by release of EDHF that elicits dilation through activation of KCa channels. If, however, sufficient NO and superoxide combine to form peroxynitrite, this compensatory mechanism of dilation could be attenuated (Figure).
The mechanisms by which KCa activity is altered by redox state are not well understood. There are numerous potential ways oxidative or nitrosative stress can influence KCa activity. ROS could modulate channel structure through alteration of tyrosine, cysteine, or methionine groups in key pore-forming regions of the protein or in the regions of calcium sensitivity. Wang et al70 provided evidence that redox modulation of cysteine thiol groups in the cytoplasmic domain can modulate BKCa opening. Donation of electrons to sulfhydryl groups increased, whereas oxidation reduced isolated channel opening probability in tracheal smooth muscle cells.70 Baseline activity could be moved in either direction by changing the oxidation state, indicating that a change in cellular redox state could serve as a physiological control over channel activity, membrane potential, and smooth muscle tone. These data also raise the possibility that key cysteine residues are situated in close proximity to the calcium-binding site of the channel.70 Others also have shown that cysteine oxidizing agents and H2O2 inhibit BKCa by modifying the cysteine residues accessible from the intracellular side.65,67
Recent electrophysiological studies using site-direct mutagenesis suggest that H2O2 and peroxynitrite but not superoxide markedly impair BKCa channel function by targeting a cysteine residue near the Ca2+ binding site of the BKCa -subunit.57,67 Interestingly, specific oxidation of methionine residues of the same vascular BKCa lead to activation.67 Thus, KCa is modulated not only by the magnitude but also by the nature of the oxidative stress applied. This mechanism of redox regulation of K-channel activity is important in other K-channels as well.71
These findings add another level of complexity to the effect of redox modulation of KCa activity because not only cellular redox state but also the effects of different targets for redox protein modification must be considered. These effects may help to explain the seemingly disparate responses observed to either oxidative or reductive stress on channel activity.60,67,70 The response of BKCa to H2O2 is dependent on the cell type and experimental conditions, with both inhibitory67,72 and occasionally excitatory responses observed.60,64
Other mechanisms may also account for ROS modulation of KCa activity. ROS such as NO stimulate sarcoplasmic/endoplasmic reticulum calcium ATPase, thereby increasing calcium uptake into endoplasmic reticulum in VSMCs. This leads to a decrease in intracellular calcium and altered channel activity.73 ROS might also modulate activity of channel-associated proteins or ß-subunits that are rarely examined in preparations of reconstituted channels. Redox-sensitive protein kinases serve as a signaling pathway that regulates intracellular calcium and may thereby alter BKCa activity.74 Finally, ROS might alter channel protein trafficking and change the number of functional channels within a cell. Each of these defined and potential sources of modulation must be considered when examining redox influences on channel activity, and each requires further study to provide a more complete understanding of oxidative alteration of vascular hyperpolarization.
In summary, current data on the effect of oxidative stress on KCa channel activity in VSMC suggest that O2
has little effect on BKCa function. H2O2, depending on the tissue type and experimental condition, may have both excitatory and inhibitory influence on BKCa, whereas ONOO– decreases activity. These differential responses may serve as a homeostatic mechanism to regulate resting membrane potential during enhanced oxidative stress in disease states.
|
Modulation of Kv Activity by Redox Mechanisms |
|---|
|
TopAbstractIntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
Voltage-dependent potassium channels represent a diverse family of outwardly rectifying potassium channels, present in the vasculature. Similar to BKCa, the Kv channel is also a heteromultimeric protein composed of transmembrane
and cytosolic ß subunits. The pore-forming region is located between S5 and S6, and the voltage sensor is at S4 of the subunit.75,76 The intracellular side of P loop has the binding sites for compounds such as 4-AP, tetraethylammonium, and quinidine.77 Kvß subunits are attached to the NH3 terminal of the -subunit and alter channel kinetics and modify cell surface expression.78–80 Kv channels represent a diverse family of channels, of which Kv1 (Shaker-related) family is the most prominently expressed in the vasculature.81 However, recent studies suggest that in addition to Kv1 channels, the Kv2, Kv3, Kv4, and Kv9 families also may participate in regulating vasomotor tone in some vascular beds.82–84 Kv channels contribute to resting vascular tone because blocking with 4-aminopyridine (4-AP), an inhibitor of the Kv channel family, produces substantial constriction.8,85 Physiological chemical stimuli including histamine86 and angiotensin87 may also elicit constriction through inhibition of Kv channels. Because Kv channels are activated by VSMC membrane depolarization, they likely serve to modulate vasoconstriction associated with changes in membrane potential. Kv channels also participate in pathophysiologically important mechanisms of vasodilation. ß-adrenergic and other cAMP-mediated dilator responses are in part Kv-dependent.88,89
Kv susceptibility to oxidative stress has been examined in several models. Duprat et al90 observed that the activity of cloned Shaker K-channels (Kv1.3, Kv1.4, and Kv1.5) from T lymphocytes, heart, and brain was markedly inhibited by ROS, whereas Kv1.2, Kv2.1, and Kv4.1 were resistant.
We have examined the effect of redox stress on Kv in the coronary vasculature. In rat coronary small arteries, 4-AP, produces a dose-dependent constriction.8 When vessels are incubated in elevated levels of glucose, an SOD-inhibitable reduction in constriction to 4-AP is observed. These data indicate that hyperglycemia is associated with production of excess superoxide which reduces Kv opening in VSMCs.
This effect of oxidative stress on Kv function was confirmed in separate studies. Dilation to the ß-adrenergic agonist, isoproterenol, which increases production of cAMP, is mediated in part by Kv because the dilation is blocked by 4-AP.89 Exposure to elevated levels of glucose inhibits coronary dilation to isoproterenol and to forskolin, a selective activator of adenylate cyclase.89 Interestingly, the production of cAMP was not affected by high glucose,89 suggesting that the inhibitory effect occurred distal in the signaling pathway. The 4-AP inhibitable component of the dilation was reduced by incubation in high glucose, supporting the idea that ROS inhibit dilation through an effect on Kv channels.
We examined more directly the effect of superoxide generated by the addition of xanthine and xanthine oxidase on Kv activity in freshly isolated rat coronary smooth muscle cells using patch clamping with a whole cell configuration.8 Superoxide reduced 4-AP–sensitive potassium current density. Reduced 4-AP–sensitive current was also observed in cells from arteries exposed to high glucose. The reduced current was not caused by a change in osmolarity because incubation of vessels in an equiosmolar concentration of L-glucose (not metabolized and unable to stimulate superoxide formation) rather than D-glucose had no effect on current density. Importantly, the 4-AP–sensitive portion of the whole cell potassium current was diminished by incubation in elevated glucose. The role of ROS in this response to high glucose is evident by the fact that SOD with or without catalase partially restored the Kv current density.8 In studies of coronary vasomotion, constriction to 4-AP was diminished by high-glucose exposure and was restored by SOD plus CAT.8 This contrasts with the reconstituted Shaker channels described,90 in which xanthine oxidase did not alter channel activity. The difference between native channels in coronary smooth muscle cells and cloned channels examined in expression systems might be caused by the relatively low concentration of xanthine and xanthine oxidase applied in the expression system or to the lack of ß-subunits in the expression system, which may reduce redox sensitivity to ROS stimulation as discussed. Nonetheless, ROS, probably superoxide, impair Kv function in the coronary vasculature. This likely contributes to the reduced coronary Kv activity during elevations in ambient glucose.
Studies by Wang et al91 examined the direct effect of H2O2 on Kv channel activity in xenopus oocyte expressing Kv1.2. H2O2 enhanced more Kv1.2 current when -subunit and ß1.2-subunits were both expressed in the cell than when channels were reconstituted from the -subunit alone. Studies by Bahring et al92 suggest that cloned Kv ß subunits confer redox sensitivity because they contain an active oxidoreductase domain with a NADPH cofactor binding pocket and substrate binding site. Therefore, Kvß subunit may be an important target site for reactive oxygen species signaling.
In summary, O2 generated exogenously or by hyperglycemia inhibits Kv channel activity in coronary arterioles. H2O2 increases coronary Kv current and function. However, the effect of H2O2 on Kv function during physiological conditions remains to be explored.
|
Vascular ATP-Sensitive Potassium Channels (KATP) and Oxidative Stress |
|---|
|
TopAbstractIntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
KATP are hetero-octamers composed of 4 subunits of the Kir 6.0 family of potassium channels (Kir 6.1 or Kir 6.2) linked with 4 SUR subunits with binding domains for phosphonucleotides or sulfonylureas (SUR 1 or SUR 2). KATP channels are present in multiple vasculature cell types (endothelial cells,36,93 VSMC36,94) and in different sites within the cell (sarcolemma, mitochondria, and nucleus).95,96 The molecular composition of KATP depends on the cellular location. VSMC sarcolemmal membranes are thought to express primarily the Kir 6.1 and SUR 2B isoforms based on electrophysiological studies.
Opening of KATP on VSMC elicits hyperpolarization and relaxation of isolated vessels and vasodilation of tissues in response to released tissue metabolites. Intracellular ADP acting on a discrete site within the SUR subunit increases KATP conductance, whereas adenosine triphosphate (ATP) has the opposite effect. Thus the ratio of ATP/ADP determines channel activity in a manner that is consistent with KATP, playing an important role in metabolic regulation of vasomotor tone. As local metabolism increases, the ATP/ADP ratio decreases, enhancing the opening probability of KATP channels, resulting in VSMC relaxation and vasodilation. As the metabolic rate decreases, the process reverses with an increase in vasomotor tone. A variety of in vivo and in vitro studies support the role of KATP channels in the mechanism of metabolic and ischemic vasodilation.36,37,97,98
Increases in metabolic activity not only decrease the ATP/ADP ratio but also increase the ambient oxidative state. Therefore, redox sensitivity of KATP would be expected to affect vasomotor tone through metabolic dilator mechanisms. Ross and Armstead observed reduced dilation to the KATP opener cromakalim in cerebral arterioles exposed to an environment with excess superoxide.56
The pathophysiological importance of redox effects on KATP function was studied by Erdos et al in cerebral arterioles using a rat model of insulin resistance.99 The KATP opener pinacidil was used to induce dilation in isolated cannulated arterioles. Pinacidil-induced dilation was reduced in fructose-fed rats but was completely restored by treatment with SOD and catalase. Therefore, oxidative stress in this model reduced KATP activity. Some caution should be noted when antioxidants are used to modulate the redox state and KATP activity because some antioxidants have direct effects on KATP function. L-cysteine, dimethylsulfoxide, or salicylate block cerebral arteriolar KATP responses through a mechanism independent of their oxidant scavenging properties.100
To the extent that the fructose model of insulin resistance mimics the diabetic state, observations from Busija’s laboratory99 suggest that it is the oxidative stress associated with diabetes that may account for reduced KATP function. Miura et al have examined this question in coronary arterioles isolated from humans with and without diabetes and coronary artery disease (CAD).36 Coronary arteriolar dilation to aprikalim, a selective KATP opener, is reduced in subjects with type 1 or type 2 diabetes and CAD compared with those with CAD but without diabetes. Dilation to nitroprusside, which occurs by a KATP-independent mechanism, was similar in both groups.36 When patients were stratified according to presence or absence of hypertension, hyperlipidemia, or heart failure, no influence on dilation to aprikalim was observed.36 It is important to note that some patients with diabetes chronically ingest KATP channel blockers in the form of sulfonylureas such as glibenclamide to maintain serum insulin levels. It is conceivable that these medications might have a residual effect on excised tissue, contributing to the impaired dilation to the KATP opener aprikalim. To test this possibility, 2 vessels from each of several subjects were incubated with either glibenclamide or saline for several hours, washed, and tested with aprikalim.36 Dilation to aprikalim was similar between vessels suggesting no effect of any retained glibenclamide.
In separate experiments, KATP was shown to contribute substantially to hypoxic dilation in human coronary arterioles. In these studies, cannulated arterioles reversibly and reproducibly dilated by 80% during 15 minutes of exposure to hypoxic media.36 Similar to aprikalim, maximum dilation to hypoxia was significantly reduced in subjects with diabetes.36 Dilation was fully restored with antioxidant treatment (MnTBAP). Thus, impaired KATP function, likely the result of increased oxidative stress, contributes to impaired hypoxic dilation in patients with diabetes mellitus. This impaired dilation could contribute to the worse prognosis in subjects with CAD who also have diabetes.
The different composition of KATP subunits in the vasculature and myocardium suggests that there could be a differential response to oxidative stress. In contrast to vascular KATP, which are inhibited by superoxide, evidenced by a reduction in whole-cell channel activity (unpublished observations) and by reduced dilation to KATP openers in cerebral vessels,56 activity of KATP in cardiac myocytes is facilitated by oxidative stress. Tokube et al demonstrated that superoxide increased KATP current and isolated channel conductance in guinea pig heart.101,102 This facilitation appears to involve an effect on the ATP binding domain of the SUR subunit.101 A similar activation was not observed on exposure of Kir channels to superoxide.
A role for superoxide or H2O2 in facilitating cardiac KATP opening was observed by An et al.103 In isolated myocytes from guinea pig hearts, ROS released by isoflurane sensitized sarcolemmal KATP channel opening to pinacidil. However, the nature of the ROS responsible for this effect was not defined.
In summary, KATP channels contribute to metabolic vasodilation in the coronary circulation. In disease states associated with elevated oxidative stress, such as diabetes, dilation to KATP opening is impaired but can be restored with a scavenger of superoxide. This superoxide-mediated impairment of vascular KATP function contrasts with myocardial KATP channels, which appear to be activated in the presence of ROS. Future studies are needed to determine the molecular mechanisms involved.
|
Summary |
|---|
|
TopAbstractIntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
Redox mechanisms clearly influence the activity of several vascular potassium channels and therefore may serve as an important modulator of vasomotor tone and tissue perfusion during ischemia, changes in metabolism, and in response to agonists. ROS generated within the vascular wall or from underlying tissue reduce bioactivity of NO, thereby impairing an important mechanism of vasodilation. In the microvasculature, hyperpolarization mechanisms of dilation typically predominate and often compensate for loss of NO dilation in the presence of disease. However, hyperpolarization dilator mechanisms, which are largely mediated through opening of VSMC sarcolemmal potassium channels, are also exposed to the same oxidative milieu in disease that quenches NO. In this setting, certain dilator mechanisms may be preserved (eg, EDHF-mediated activation of KCa channels), whereas others may also be impaired (eg, hypoxic dilation involving KATP opening, ß-adrenergic opening of Kv). The vasodilator capacity of a vascular bed in the presence of disease depends on the nature of the redox species present, as well as the integrity of endogenous antioxidant mechanisms. These factors contribute to the overall integrity of hyperpolarization-mediated vasodilation.
|
Acknowledgments |
|---|
Preparation of this article was supported by grants from the National Institutes of Health and Veterans Administration.
Received September 29, 2004; accepted January 26, 2005.
|
References |
|---|
|
TopAbstractIntroductionRedox Modulation of KCa...Modulation of Kv Activity...Vascular ATP-Sensitive Potassium...SummaryReferences |
|---|
1. Laurindo FRM, Pedro MA, Barbeiro HV, Pileggi F, Carvalho MHC, Augusto O, da Luz PL. Vascular free radical release: ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res. 1994; 74: 700–709.
2. Chiu JJ, Wung BS, Shyy JY, Hsieh HJ, Wang DL. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol. 1997; 17: 3570–3577.
3. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res. 1998; 82: 1094–1101.
4. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res. 2003; 92: e31–e40.
5. Hishikawa K, Luscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circ. 1997; 96: 3610–3616.
6. Oeckler RA, Kaminski PM, Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res. 2003; 92: 23–31.
7. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circ. 1997; 96: 25–28.
8. Liu Y, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res. 2001; 89: 146–152.
9. Huang A, Sun D, Kaley G, Koller A. Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations. Circ Res. 1998; 83: 960–965.
10. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circ. 2003; 108: 1253–1258.
11. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998; 82: 1298–1305.
12. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circ. 1995; 92: 898–903.
13. Heitzer T, Just H, Muenzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smoker. Circ. 1996; 94: 6–9.
14. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circ. 2003; 107: 2342–2347.
15. Stokes KY, Clanton EC, Russell JM, Ross CR, Granger DN. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res. 2001; 88: 499–505.
16. Rosen GM, Freeman BA. Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci U S A. 1984; 81: 7269–7273.
17. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000; 106: 1521–1530.[Medline] [Order article via Infotrieve]
18. Ciriello J, Lawrence D, Pittman QJ. Electrophysiological identification of neurons in the parabrachial nucleus projecting directly to the hypothalamus in the rat. Brain Res. 1984; 322: 388–392.[CrossRef][Medline] [Order article via Infotrieve]
19. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, Kugiyama K, Ogawa H, Yasue H. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol. 2000; 35: 1860–1866.
20. Raij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens. 2001; 19: 891–897.[CrossRef][Medline] [Order article via Infotrieve]
21. Brown BG, Lee AB, Bolson EL, Dodge HT. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circ. 1984; 70: 18–24.
22. Heusch G, Deussen A, Thamer V. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia. J Auton Nerv Syst. 1985; 13: 311–326.[CrossRef][Medline] [Order article via Infotrieve]
23. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium [see comments]. J Am Coll Cardiol. 1989; 14: 1181–1190.[Abstract]
24. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A. 1994; 91: 1044–1048.
25. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun. 1993; 18: 195–199.[Medline] [Order article via Infotrieve]
26. Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun. 1999; 263: 681–684.[CrossRef][Medline] [Order article via Infotrieve]
27. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003; 111: 1201–1209.[CrossRef][Medline] [Order article via Infotrieve]
28. Diederich D, Skopec J, Diederich A, Dai F-X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol. 1994; 266: H1153–H1161.
29. Ammar RF, Gutterman DD, Brooks LA, Dellsperger KC. Impaired dilation of coronary arterioles during increases in myocardial O(2) consumption with hyperglycemia. Am J Physiol Endocrinol Metab. 2000; 279: E868–E874.
30. Najibi S, Cowan CL, Palacino JJ, Cohen RA. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 1994; 266: H2061–H2067.
31. Kaw S, Hecker M. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery [In Process Citation]. Naunyn-Schmiedebergs Arch Pharmacol. 1999; 359: 133–139.[CrossRef][Medline] [Order article via Infotrieve]
32. Ellis A, Triggle CR. Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone. Can J Physiol Pharmacol. 2003; 81: 1013–1028.[CrossRef][Medline] [Order article via Infotrieve]
33. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A. 2000; 97: 9747–9752.
34. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, Kaley G. In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol Heart Circ Physiol. 2000; 278: H762–H768.
35. Miura H, Wachtel RE, Liu Y, Loberiza FR, Jr., Saito T, Miura M, Gutterman DD. Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels. Circ. 2001; 103: 1992–1998.
36. Miura H, Wachtel RE, Loberiza FR, Jr., Saito T, Miura M, Nicolosi AC, Gutterman DD. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res. 2003; 92: 151–158.
37. Kanatsuka H, Sekiguchi N, Sato A, Akai K, Wang Y, Komaru T, Ashikawa K, Takishima T. Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart. Circ Res. 1992; 71: 912–922.
38. Kohler R, Degenhardt C, Kuhn M, Runkel N, Paul M, Hoyer J. Expression and function of endothelial Ca(2+)-activated K(+) channels in human mesenteric artery: A single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ. Circ Res. 2000; 87: 496–503.
39. Brakemeier S, Eichler I, Knorr A, Fassheber T, Kohler R, Hoyer J. Modulation of Ca2+-activated K+ channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species. Kidney Int. 2003; 64: 199–207.[CrossRef][Medline] [Order article via Infotrieve]
40. Saito T, Fujiwara Y, Fujiwara R, Hasegawa H, Kibira S, Miura H, Miura M. Role of augmented expression of intermediate-conductance Ca2+-activated K+ channels in postischaemic heart. Clin Exp Pharmacol Physiol. 2002; 29 (4): 324–9.[CrossRef][Medline] [Order article via Infotrieve]
41. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH. Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function. Circ Res. 1999; 85: e33–e43.
42. Burnham MP, Bychkov R, Feletou M, Richards GR, Vanhoutte PM, Weston AH, Edwards G. Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol. 2002; 135: 1133–1143.[CrossRef][Medline] [Order article via Infotrieve]
43. Crane GJ, Garland CJ. Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. Br J Pharmacol. 2004; 142: 43–50.[CrossRef][Medline] [Order article via Infotrieve]
44. McCobb DP, Fowler NL, Featherstone T, Lingle CJ, Saito M, Krause JE, Salkoff L. A human calcium-activated potassium channel gene expressed in vascular smooth muscle. Am J Physiol. 1995; 269 (3 Pt 2): H767–H777.
45. Weiger TM, Hermann A, Levitan IB. Modulation of calcium-activated potassium channels. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2002; 188: 79–87.[CrossRef][Medline] [Order article via Infotrieve]
46. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol. 2003; 285: H2345–H2354.
47. Wei EP, Kontos HA, Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol. 1996; 271: H1262–H1266.
48. Ahern GP, Hsu SF, Jackson MB. Direct actions of nitric oxide on rat neurohypophysial K+ channels. J Physiol. 1999; 520 (Pt 1): 165–76.
49. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, Gutterman DD. Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res. 2002; 91: 1070–1076.
50. Miura H, Liu Y, Gutterman DD. Human Coronary Arteriolar Dilation to Bradykinin Depends on Membrane Hyperpolarization. Circ. 1999; 99: 3132–3138.
51. Zhang DX, Zou AP, Li PL. Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries. Circ Res. 2001; 88: 824–831.
52. Armstead WM. Vasopressin induced cyclooxygenase dependent superoxide generation contributes to K(+) channel function impairment after brain injury. Brain Res. 2001; 910: 19–28.[CrossRef][Medline] [Order article via Infotrieve]
53. Armstead WM. Role of activation of calcium-sensitive K+ channels in NO- and hypoxia- induced pial artery vasodilation. Am J Physiol. 1997; 272: H1785–H1790.
54. Armstead WM. Role of activation of calcium-sensitive K+ channels in NO- and hypoxia-induced pial artery vasodilation. Am J Physiol. 1997; 272 (4 Pt 2): H1785–H1790.
55. Holland M, Langton PD, Standen NB, Boyle JP. Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol. 1996; 117: 119–129.[Medline] [Order article via Infotrieve]
56. Ross J, Armstead WM. Differential role of PTK and ERK MAPK in superoxide impairment of K(ATP) and K(Ca) channel cerebrovasodilation. Am J Physiol Regul Integr Comp Physiol. 2003; 285: R149–R154.
57. Tang XD, Garcia ML, Heinemann SH, Hoshi T. Reactive oxygen species impair Slo1 BK channel function by altering cysteine-mediated calcium sensing. Nat Struct Mol Biol. 2004; 11: 171–178.[CrossRef][Medline] [Order article via Infotrieve]
58. Iida Y, Katusic ZS. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke. 2000; 31: 2224–2230.
59. Thengchaisri N, Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol. 2003; 285: H2255–H2263.
60. Barlow RS, White RE. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol. 1998; 275 (4 Pt 2): H1283–H1289.
61. Burke-Wolin T, Abate CJ, Wolin MS, Gurtner GH. Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3',5'-cyclic monophosphate. Am J Physiol. 1991; 261: L393–L398.
62. Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol. 2002; 283: H406–H411.
63. Park MK, Lee SH, Lee SJ, Ho WK, Earm YE. Different modulation of Ca-activated K channels by the intracellular redox potential in pulmonary and ear arterial smooth muscle cells of the rabbit. Pflugers Arch. 1995; 430: 308–314.[CrossRef][Medline] [Order article via Infotrieve]
64. Bychkov R, Pieper K, Ried C, Milosheva M, Bychkov E, Luft FC, Haller H. Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells. Circ. 1999; 99: 1719–1725.
65. DiChiara TJ, Reinhart PH. Redox modulation of hslo Ca2+-activated K+ channels. J Neurosci. 1997; 17: 4942–4955.
66. Soto MA, Gonzalez C, Lissi E, Vergara C, Latorre R. Ca(2+)-activated K+ channel inhibition by reactive oxygen species. Am J Physiol Cell Physiol. 2002; 282: C461–C471.
67. Tang XD, Daggett H, Hanner M, Garcia ML, McManus OB, Brot N, Weissbach H, Heinemann SH, Hoshi T. Oxidative regulation of large conductance calcium-activated potassium channels. J Gen Physiol. 2001; 117: 253–274.
68. Lang RJ, Harvey JR, Mulholland EL. Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L-cysteine activation of Ca2+-activated K+ (BKCa) channels in myocytes of the guinea-pig taenia caeca. Br J Pharmacol. 2003; 139: 1153–1163.[CrossRef][Medline] [Order article via Infotrieve]
69. Brzezinska AK, Gebremedhin D, Chilian WM, Kalyanaraman B, Elliott SJ. Peroxynitrite reversibly inhibits Ca(2+)-activated K(+) channels in rat cerebral artery smooth muscle cells. Am J Physiol Heart Circ Physiol. 2000; 278: H1883–H1890.
70. Wang ZW, Nara M, Wang YX, Kotlikoff MI. Redox regulation of large conductance Ca(2+)-activated K+ channels in smooth muscle cells. J Gen Physiol. 1997; 110: 35–44.
71. Ciorba MA, Heinemann SH, Weissbach H, Brot N, Hoshi T. Modulation of potassium channel function by methionine oxidation and reduction. Proc Natl Acad Sci U S A. 1997; 94: 9932–9937.
72. Weitzberg E, Lundberg JO. Nonenzymatic nitric oxide production in humans. Nitric Oxide. 1998; 2: 1–7.[CrossRef][Medline] [Order article via Infotrieve]
73. Adachi T, Matsui R, Xu S, Kirber M, Lazar HL, Sharov VS, Schoneich C, Cohen RA. Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res. 2002; 90: 1114–1121.
74. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol. 2004; 165: 219–226.
75. Pongs O. Molecular biology of voltage-dependent potassium channels. Physiol Rev. 1992; 72 (4 Suppl): S69–S88.
76. Clapp LH, Tinker A. Potassium channels in the vasculature. Curr Opin Nephrol Hyp. 1998; 7: 91–98.
77. Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000; 52: 557–594.
78. Morales MJ, Castellino RC, Crews AL, Rasmusson RL, Strauss HC. A novel beta subunit increases rate of inactivation of specific voltage-gated potassium channel alpha subunits. J Biol Chem. 1995; 270: 6272–6277.
79. Castellino RC, Morales MJ, Strauss HC, Rasmusson RL. Time- and voltage-dependent modulation of a Kv1.4 channel by a beta-subunit (Kv beta 3) cloned from ferret ventricle. Am J Physiol. 1995; 269 (1 Pt 2): H385–H391.
80. England SK, Uebele VN, Shear H, Kodali J, Bennett PB, Tamkun MM. Characterization of a voltage-gated K+ channel beta subunit expressed in human heart. Proc Natl Acad Sci U S A. 1995; 92: 6309–6313.
81. Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation. 2002; 9: 243–257.[CrossRef][Medline] [Order article via Infotrieve]
82. Archer SL, Souil E, nh-Xuan AT, Schremmer B, Mercier JC, El YA, Nguyen-Huu L, Reeve HL, Hampl V. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest. 1998; 101: 2319–2330.[Medline] [Order article via Infotrieve]
83. Hulme JT, Coppock EA, Felipe A, Martens JR, Tamkun MM. Oxygen sensitivity of cloned voltage-gated K(+) channels expressed in the pulmonary vasculature. Circ Res. 1999; 85: 489–497.
84. Patel AJ, Lazdunski M, Honore E. Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J. 1997; 16: 6615–6625.[CrossRef][Medline] [Order article via Infotrieve]
85. Michelakis ED, Rebeyka I, Wu X, Nsair A, Thebaud B, Hashimoto K, Dyck JR, Haromy A, Harry G, Barr A, Archer SL. O2 sensing in the human ductus arteriosus: regulation of voltage-gated K+ channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res. 2002; 91: 478–486.
86. Ishikawa T, Hume JR, Keef KD. Modulation of K+ and Ca2+ channels by histamine H1-receptor stimulation in rabbit coronary artery cells. J Physiol. 1993; 468: 379–400.
87. Clement-Chomienne O, Walsh MP, Cole WC. Angiotensin II activation of protein kinase C decreases delayed rectifier K+ current in rabbit vascular myocytes. J Physiol (Lond). 1996; 495 (Pt 3): 689–700.
88. Aiello EA, Malcolm AT, Walsh MP, Cole WC. Beta-adrenoceptor activation and PKA regulate delayed rectifier K+ channels of vascular smooth muscle cells. Am J Physiol. 1998; 275 (2 Pt 2): H448–H459.
89. Li H, Chai Q, Gutterman DD, Liu Y. Elevated glucose impairs cAMP-mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003; 285: H1213–H1219.
90. Duprat F, Guillemare E, Romey G, Fink M, Lesage F, Lazdunski M, Honore E. Susceptibility of cloned K+ channels to reactive oxygen species. Proc Natl Acad Sci U S A. 1995; 92: 11796–11800.
91. Wang Z, Kiehn J, Yang Q, Brown AM, Wible BA. Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits. J Biol Chem. 1996; 271: 28311–28317.
92. Bahring R, Milligan CJ, Vardanyan V, Engeland B, Young BA, Dannenberg J, Waldschutz R, Edwards JP, Wray D, Pongs O. Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits. J Biol Chem. 2001; 276: 22923–22929.
93. Schnitzler MM, Derst C, Daut J, Preisig-Muller R. ATP-sensitive potassium channels in capillaries isolated from guinea-pig heart. J Physiol. 2000; 525 (Pt 2): 307–17.
94. Beech DJ, Zhang H, Nakao K, Bolton TB. K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol. 1993; 110: 573–582.[Medline] [Order article via Infotrieve]
95. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991; 352: 244–247.[CrossRef][Medline] [Order article via Infotrieve]
96. Quesada I, Rovira JM, Martin F, Roche E, Nadal A, Soria B. Nuclear KATP channels trigger nuclear Ca(2+) transients that modulate nuclear function. Proc Natl Acad Sci U S A. 2002; 99: 9544–9549.
97. Duncker DJ, Van Zon NS, Pavek TJ, Herrlinger SK, Bache RJ. Endogenous adenosine mediates coronary vasodilation during exercise after k+atp channel blockade. J Clin Invest. 1995; 95: 285–295.
98. Komaru T, Lamping KG, Eastham CL, Dellsperger KC. Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ Res. 1991; 69: 1146–1151.
99. Erdos B, Simandle SA, Snipes JA, Miller AW, Busija DW. Potassium channel dysfunction in cerebral arteries of insulin-resistant rats is mediated by reactive oxygen species. Stroke. 2004; 35: 964–969.
100. Wei EP, Kontos HA, Beckman JS. Antioxidants inhibit ATP-sensitive potassium channels in cerebral arterioles. Stroke. 1998; 29: 817–822.
101. Tokube K, Kiyosue T, Arita M. Openings of cardiac Katp channel by oxygen free radicals produced by xanthine oxidase reaction. Am J Physiol. 1996; 271: H478–H489.
102. Tokube K, Kiyosue T, Arita M. Effects of hydroxyl radicals on KATP channels in guinea-pig ventricular myocytes. Pflugers Arch. 1998; 437: 155–157.[CrossRef][Medline] [Order article via Infotrieve]
103. An J, Stadnicka A, Kwok WM, Bosnjak ZJ. Contribution of reactive oxygen species to isoflurane-induced sensitization of cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil. Anesthesiol. 2004; 100: 575–580.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  M. A. Potenza, F. Addabbo, and M. Montagnani Vascular actions of insulin with implications for endothelial dysfunction Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E568 - E577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species Physiol Rev, January 1, 2009; 89(1): 27 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. R. Williams, G. K. Fyfe, C. P. Sibley, P. N. Baker, and S. L. Greenwood K+ channel inhibition modulates the biochemical and morphological differentiation of human placental cytotrophoblast cells in vitro Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1204 - R1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kinoshita, N. Matsuda, H. Kaba, N. Hatakeyama, T. Azma, K. Nakahata, Y. Kuroda, K. Tange, H. Iranami, and Y. Hatano Roles of Phosphatidylinositol 3-Kinase-Akt and NADPH Oxidase in Adenosine 5'-Triphosphate-Sensitive K+ Channel Function Impaired by High Glucose in the Human Artery Hypertension, September 1, 2008; 52(3): 507 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-G. Ryou, J. Sun, K. N. Oguayo, E. B. Manukhina, H. F. Downey, and R. T. Mallet Hypoxic Conditioning Suppresses Nitric Oxide Production upon Myocardial Reperfusion Experimental Biology and Medicine, June 1, 2008; 233(6): 766 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Duncker and D. Merkus Exercise hyperaemia in the heart: the search for the dilator mechanism J. Physiol., September 15, 2007; 583(3): 847 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Bearden Advancing age produces sex differences in vasomotor kinetics during and after skeletal muscle contraction Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1274 - R1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumoto, M. Kakami, E. Noguchi, T. Kobayashi, and K. Kamata Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1480 - H1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kajiya, M. Hirota, Y. Inai, T. Kiyooka, T. Morimoto, T. Iwasaki, K. Endo, S. Mohri, J. Shimizu, T. Yada, et al. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2737 - H2744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu, R.H. Henning, E. Lipsic, A. van Buiten, W.H. van Gilst, and H. Buikema Acetylcholine stimulated dilatation and stretch induced myogenic constriction in mesenteric artery of rats with chronic heart failure Eur J Heart Fail, February 1, 2007; 9(2): 144 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Szerafin, N. Erdei, T. Fulop, E. T. Pasztor, I. Edes, A. Koller, and Z. Bagi Increased Cyclooxygenase-2 Expression and Prostaglandin-Mediated Dilation in Coronary Arterioles of Patients With Diabetes Mellitus Circ. Res., September 1, 2006; 99(5): e12 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Lyle and K. K. Griendling Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology, August 1, 2006; 21: 269 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wareing, X. Bai, F. Seghier, C. M. Turner, S. L. Greenwood, P. N. Baker, M. J. Taggart, and G. K. Fyfe Expression and function of potassium channels in the human placental vasculature Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R437 - R446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kinoshita, T. Azma, H. Iranami, K. Nakahata, Y. Kimoto, M. Dojo, O. Yuge, and Y. Hatano Synthetic Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Restore Impaired Vasorelaxation via ATP-Sensitive K+ Channels by High Glucose J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 312 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Larsen and D. D. Gutterman Hypoxia, coronary dilation, and the pentose phosphate pathway Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2169 - H2171. [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Heistad Oxidative Stress and Vascular Disease: 2005 Duff Lecture Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 689 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Leffler, H. Parfenova, J. H. Jaggar, and R. Wang Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation J Appl Physiol, March 1, 2006; 100(3): 1065 - 1076. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||